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ibronectin (FN) assembly into a ﬁbrillar extracellular
matrix is a stepwise process requiring participation
 
from multiple FN domains. Fibril formation is regu-
lated in part by segments within the ﬁrst seven type III
 
repeats (III
 
1–7
 
). To deﬁne the speciﬁc function(s) of this
region, recombinant FNs (recFNs) containing an overlapping
set of deletions were tested for the ability to assemble
 
into ﬁbrils. Surprisingly,
 
 
 
recFN lacking type III repeat III
 
1
 
(FN
 
 
 
III
 
1
 
), which contains a cryptic FN binding site and has
been suggested to be essential for ﬁbril assembly, formed a
matrix identical in all respects to a native FN matrix. Similarly,
F
 
displacement of the cell binding domain in repeats III
 
9–10
 
to a position close to the NH
 
2
 
-terminal assembly domain,
as well as a large deletion spanning repeats III
 
4–7
 
, had no
effect on assembly. In contrast, two deletions that included
repeat III
 
2
 
, 
 
 
 
III
 
1–2
 
 and 
 
 
 
III
 
2–5
 
, caused signiﬁcant reductions
 
in ﬁbril elongation, although binding of FN to the cell
surface and initiation of assembly still proceeded. Using
 
individual repeats in binding assays, we show that III
 
2 
 
but
not III
 
1 
 
contains an FN binding site. Thus, these results
pinpoint repeat III
 
2
 
 as an important module for FN–FN
interactions during ﬁbril growth.
 
Introduction
 
Fibronectin (FN)* functions from within a fibrillar matrix,
and proper formation of matrix fibrils is crucial for control-
ling tissue structure and cell motility, growth, and differen-
tiation (Mosher, 1989; Hynes, 1990; Schwarzbauer and
Sechler, 1999). Multiple FN domains have been implicated
 
in intermolecular interactions required for the assembly process,
including FN’s dimer structure and NH
 
2
 
-terminal assembly
domain (McKeown-Longo and Mosher, 1985; McDonald
et al., 1987; Schwarzbauer, 1991). Integrin binding to the
arg-gly-asp (RGD) cell binding sequence within the cell
binding domain is necessary for initiation of fibril forma-
tion, but not for fibril elongation (Sechler et al., 1996). In
the absence of the synergy site,
 
  
 
5
 
 
 
1-mediated assembly is
stalled, suggesting that fibril growth requires strong interac-
tions between FN and integrins (Sechler et al., 1997). This
is further supported by the demonstration that activation of
 
 
 
4
 
 
 
1, 
 
 
 
v
 
 
 
3, and 
 
 
 
IIb
 
 
 
3 integrins can promote FN assem-
bly (Wu et al., 1995, 1996; Wennerberg et al., 1996; Sechler
et al., 2000).
 
FN–FN interactions are also important for fibril forma-
 
tion. The major site of interaction is the NH
 
2
 
-terminal
assembly domain which consists of repeats I
 
1–5
 
 and binds
FN and many other molecules (Mosher, 1989; Hynes,
1990; Schwarzbauer, 1991). Other FN binding sites have
been localized to the first one or two type III repeats (Morla
and Ruoslahti, 1992; Aguirre et al., 1994; Hocking et al.,
1994; Ingham et al., 1997), the cell binding repeat III
 
10
 
(Hocking et al., 1996), and the COOH-terminal heparin
binding domain (III
 
12–14
 
) (Bultmann et al., 1998). Each of
 
these sites interacts with the NH
 
2
 
-terminal assembly domain.
 
Results from binding, inhibition, and matrix assembly
studies show that FN fibrils form via a multistep process
(McKeown-Longo and Mosher, 1983; Schwarzbauer and
Sechler, 1999). During the initiation stage of assembly,
integrin binding immobilizes dimeric FN and promotes
formation of deoxycholate (DOC)-soluble fibrils in a process
 
that depends on the NH
 
2
 
-terminal assembly domain. Muta-
tions that affect the RGD cell binding sequence or the NH
 
2
 
-
terminal domain ablate fibril formation (Schwarzbauer, 1991;
 
Sottile et al., 1991; Sechler et al., 1996; Sottile and Mosher, 1997).
Assembly then progresses into a growth phase that involves
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incorporation of additional FN dimers into nascent fibrils,
fibril elongation, and conversion of fibrils into a DOC-
insoluble form. The matrix is further stabilized as DOC-
insoluble FN is formed into high molecular mass multimers.
We have shown previously that a recombinant FN
(recFN) lacking the first seven type III repeats (FN
 
 
 
III
 
1–7
 
) is
able to form a fibrillar matrix, albeit at an altered rate
(Sechler et al., 1996). It appears that this set of seven repeats,
or a subset of them, has a regulatory role in FN assembly. In
this study, recFNs containing overlapping deletions across
this region were tested for the ability to form fibrils, DOC-
insoluble matrices, and high molecular mass multimers. Sur-
prisingly, deletion of repeat III
 
1
 
, a site proposed to be essen-
tial for assembly, had no detrimental effects on assembly.
Similarly, relatively large deletions of up to four type III re-
peats, as well as displacement of the cell binding domain to-
ward the NH
 
2
 
 terminus, caused no deficiencies in matrix for-
mation. However, deletions that included repeat III
 
2
 
 reduced
the assembly of a DOC-insoluble matrix and blocked fibril
elongation. Binding studies using recombinant fragments
showed that III
 
2
 
, but not III
 
1
 
, has FN binding activity. Our
results indicate that repeat III
 
2
 
 is a key element in the regula-
tion of FN–FN interactions during matrix assembly.
 
Results
 
Repeat III
 
1
 
 is not essential for FN assembly
 
To delineate the elements involved in the regulation of FN
matrix assembly, a set of recFNs containing in-frame dele-
tions within the first seven type III repeats was prepared
(Fig. 1). Of particular interest was the first type III repeat,
which has FN binding activity when in denatured form and
has been implicated in FN matrix formation (Morla and Ru-
oslahti, 1992; Aguirre et al., 1994; Hocking et al., 1994; In-
gham et al., 1997). Using the baculovirus expression system,
FN
 
 
 
III
 
1
 
 was expressed from a rat FN cDNA mutated by
PCR to eliminate the entire segment encoding repeat III
 
1
 
.
Assembly was tested using CHO K1 cells transfected with
human 
 
 
 
5 integrin cDNA (CHO
 
 
 
5) that do not assemble
an endogenous matrix (Sechler et al., 1996). FN
 
 
 
III
 
1
 
 was
assembled into a fibrillar matrix morphologically identical to
that formed by native FN (Fig. 2, A–D) or full-length
recFNA-B- (unpublished data and Sechler et al., 1996). No
differences in native and FN
 
 
 
III
 
1
 
 matrices were detected at
any of the time points studied. AtT-20 mouse pituitary cells
transfected with human 
 
 
 
5 integrin cDNA (AtT-20
 
 
 
5), a
cell line that does not express any endogenous FN (Sechler
et al., 1996), also assembled morphologically identical native
and FN
 
 
 
III
 
1
 
 matrices (Fig. 2, E and F). Therefore, in two
independent cell lines, FN matrix assembly was not altered
by the deletion of repeat III
 
1
 
.
Biochemically, FN
 
 
 
III
 
1
 
 and native FN matrices were in-
distinguishable. Equivalent amounts of both proteins were
associated with CHO
 
 
 
5 cells in the DOC-soluble fractions
(Fig. 3 A). Similar proportions of DOC-insoluble material
were formed from FN and FN
 
 
 
III
 
1
 
 during a 16-h incuba-
tion (Fig. 3 B). As has been shown previously for FN
(McKeown-Longo and Mosher, 1983; Sechler et al., 1996),
there was continued incorporation of FN
 
 
 
III
 
1
 
 into DOC-
insoluble matrices and high molecular mass aggregates (Fig.
3 B, 48 h). These data show that III
 
1
 
 is neither required for
the formation of fibrils, nor responsible for the altered rate
of assembly observed with FN
 
 
 
III
 
1–7
 
.
 
Reduced matrix accumulation in the absence of 
repeats III
 
2–5
 
In contrast to the normal matrix formed with FN
 
 
 
III
 
1
 
, dele-
tion of III
 
2–5
 
 decreased matrix accumulation. Some fibril as-
Figure 1. Schematic representation of FN and recFNs. The struc-
tural organization of FN consisting of type I (rectangles), type II 
(triangles), and type III (ovals) repeats is shown at top. Darkened ovals 
represent alternatively spliced EIIIA and EIIIB repeats that were not 
included in any recFNs. All recFNs contain the V120 variant of the 
alternatively spliced V region (cross-hatched box) as well as the 
COOH-terminal cysteine pair (S-S). The inverted triangle over 
FNrIII4–5/9–10 indicates a deleted RGD sequence; white ovals are III9–10 
in place of III4–5. All six recFNs were constructed from rat FN cDNA.
Figure 2.  Assembly of FN III1. CHO 5 cells were cultured in the 
presence of 50  g/ml pFN (A and B) or 50  g/ml FN III1 (C and D) 
for 4 (A and C) or 16 (B and D) h. AtT-20 5 cells were incubated 
with 25  g/ml pFN (E) or FN III1 (F) for 16 h. Cells were then fixed 
and FN fibrils detected by indirect immunofluorescence with 
monoclonal anti–rat FN antibody IC3. Bar, 10  m. 
Fibronectin binding and fibril growth |
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sembly was initiated, but the amount of FN
 
 
 
III
 
2–5
 
 matrix
assembled by CHO
 
 
 
5 cells was less than that of native FN,
and the distribution of fibrils was more sparse than for na-
tive FN (Fig. 4 A). Furthermore, DOC-insoluble matrix was
at least threefold less for FN
 
 
 
III
 
2–5
 
 than for native FN (Fig.
4 B). Limited conversion of DOC-soluble FN
 
 
 
III
 
2–5
 
 into
DOC-insoluble matrix suggests that this recFN is impaired
in its ability to participate in fibril growth.
Analyses of the assembly of two other deletion mutants,
FN
 
 
 
III
 
4–5
 
 and FN
 
 
 
III
 
4–7
 
, showed formation of characteris-
tic fibrils at all time points (unpublished data). Furthermore,
biochemical analyses did not reveal any defects in incorpora-
tion into DOC-insoluble matrix or the formation of high
molecular mass multimers, results similar to those observed
for FN
 
 
 
III
 
1
 
. FN
 
 
 
III
 
2–5
 
 and FN
 
 
 
III
 
4–7
 
 both lack four type
III repeats but differ in their capacity to be assembled. This
indicates that alterations in the ability to assemble matrices
cannot be attributed solely to the size of the deletion. In-
stead, there appear to be specific roles for individual type III
repeats and normal assembly of FN
 
 
 
III
 
4–5
 
 compared with
FN
 
 
 
III
 
2–5 
 
indicates that III
 
2
 
 and/or III
 
3
 
 may be important.
 
Fibril growth depends on repeats III
 
1–2
 
Because III
 
1–2
 
 has FN binding activity (Aguirre et al., 1994)
and a proteolytic fragment containing III1 plus part of III2
inhibits incorporation of FN into matrix (Chernousov et al.,
1991; Morla and Ruoslahti, 1992), we generated FN III1–2
to test whether these two repeats together comprise a matrix
regulatory region. Immunofluorescence analysis of FN as-
sembled by CHO 5 cells showed that early during assem-
Figure 3.  DOC-soluble and -insoluble FN III1. CHO 5 cells 
were incubated with 50  g/ml pFN or FN III1 for the indicated 
times and lysed in buffered DOC. DOC-soluble (A) and -insoluble 
(B) fractions were separated in 5% polyacrylamide-SDS gels without 
reduction and transferred to nitrocellulose. FN was detected on 
immunoblots with monoclonal anti-FN antibody IC3 and chemi-
luminescence reagents. Dimeric pFN and FN III1 are present 
(arrowhead) as well as high molecular mass multimers at the top of 
the stacking (bracket) and at the interface of the stacking and separating 
gels (arrow).
Figure 4.  Assembly of FN III2–5. (A) Native pFN and FN III2–5 
were added to CHO 5 cells at a concentration of 50  g/ml and 
cultured for the indicated times. Fibrils were visualized by indirect 
immunofluorescence as in Fig. 2. (B) DOC-insoluble material iso-
lated at the indicated times was analyzed under reducing conditions 
by immunoblotting with IC3 monoclonal antibody. Bar, 10  m.
Figure 5.  Assembly of FN III1–2. (A) CHO 5 cells were incubated for either 4 or 24 h in the presence of 50  g/ml FN III1–2. Monoclonal 
antibody IC3 was used to detect recFN matrix by immunofluorescence. (B) DOC-soluble and -insoluble cell lysates were isolated from 
CHO 5 cells incubated in the presence of 50  g/ml FN III1–2 or pFN for 0.5, 4, 7, 16, 24, and 48 h. DOC-soluble and -insoluble material 
was analyzed as described in Fig. 3. Arrow and bracket indicate locations of high molecular mass multimers. Dash indicates location of 
180-kD molecular mass standard. Bar, 10  m.1084 The Journal of Cell Biology | Volume 154, 2001
bly, FN III1–2 formed aggregates on the cell surface (Fig. 5
A) similar to, but much smaller than, those formed by
FN III1–7 (Sechler et al., 1996). As assembly progressed,
FN III1–2 formed mainly short fibrils between cells al-
though occasional long thin fibrils were also visible. An ex-
tensive fibrillar network was never observed even after pro-
longed incubations. Levels of DOC-insoluble material were
significantly reduced, especially at later times of assembly,
and no high molecular mass multimers were observed (Fig. 5
B). Incubations with higher concentrations of FN III1–2 did
not increase the amount of DOC-insoluble matrix (un-
published data). Unlike FNs lacking the RGD sequence,
FN III1–2 was not deficient in binding to cells. In fact, sub-
stantially more FN III1–2 than native FN was isolated as
cell-associated DOC-soluble material. This indicates that
FN III1–2 can efficiently bind to the cell surface to initiate
assembly, but is defective in the growth phase when conver-
sion from DOC-soluble to -insoluble matrix occurs.
FN lacking the RGD sequence is unable to initiate matrix
assembly but can be incorporated once assembly has been
primed by native FN (Sechler et al., 1996). However, prein-
itiation by native FN would not be expected to rescue
FN III1–2 assembly, as this protein shows a defect in fibril
growth. In fact, neither FN III1–2 nor FN III2–5 was able to
efficiently incorporate into a preformed human FN matrix.
A very few short fibrils were formed by FN III1–2 (Fig. 6 B)
and FN III2–5 fibrils were found in small patches distrib-
uted unevenly throughout the matrix (Fig. 6 C). In contrast,
an extensive fibrillar network was assembled by native FN
(Fig. 6 A). In all cases, a fibrillar human plasma FN (pFN)
matrix could be readily detected with a human FN-specific
monoclonal antibody (unpublished data). Thus, the pres-
ence of repeat III2 is required for the continued growth of
FN fibrils.
Repeat III2 contains an FN binding site
To demonstrate a requirement for III2 in FN assembly, at-
tempts were made to generate a recFN lacking repeat III2 or
with another homologous repeat in its place. Unlike the
recFNs reported here, secretion of mutant recFNs lacking
III2 from infected insect cells was very inefficient, suggesting
that in the absence of this repeat the proteins were not prop-
erly folded. We have shown previously that III1–2 purified
in soluble form from bacterial lysates is able to bind FN
(Aguirre et al., 1994). To identify the repeat responsible for FN
binding activity, maltose-binding protein (MBP) fusion pro-
Figure 6.  RecFN assembly in the presence of human FN matrix. 
CHO 5 cells were incubated with 50  g/ml human pFN for 8 h. 
Medium was then removed, cell layers were washed to remove un-
bound FN, and cells were fed with fresh medium containing 25  g/ml 
full-length recFN (A), FN III1–2 (B), or FN III2–5 (C). After incubation 
for an additional 16 h, cells were fixed and recFN fibrils detected 
with an anti–rat FN-specific monoclonal antibody. Bar, 20  m.
Figure 7.  Repeat III2 contains a FN binding site. Solid phase bind-
ing assays were used to examine binding of FN (A–C) and NH2-
terminal 70-kD fragment (B) to immobilized fusion proteins. (A and 
C) MBP and fusion proteins were coated at 2  g/ml and incubated 
with 50  g/ml rat pFN. (B) MBP-III2 coated at 4  g/ml was incubated 
with rat pFN or 70-kD fragment at increasing concentrations. Back-
ground binding to MBP was subtracted from these data. Binding was 
detected with 5G4 anti-FN monoclonal antibody for FN (A and C) or 
R457 anti–70-kD polyclonal antiserum (B). Results are presented as 
the average of normalized values from two to three experiments.Fibronectin binding and fibril growth | Sechler et al. 1085
teins containing either III1 or III2 were generated and tested
for binding in solid phase binding assays. MBP-III2, but not
MBP-III1, showed significant FN binding activity (Fig. 7 A)
that was reversed by treatment with buffered SDS (unpub-
lished data). The lack of MBP-III1 binding confirms the re-
sults of Ingham et al. (1997) who showed that native III1
does not bind to FN or its fragments. FN binding was con-
centration dependent and a complementary binding site was
localized to the 70-kD region (Fig. 7 B). Apparent dissocia-
tion constants for FN and 70 kD binding to III2 differ by
only 3.5-fold, 28 nM, and 8 nM, respectively. The higher
dissociation constant for FN may reflect a difference in af-
finity. However, it may also be due to molecular differences
between the relatively small 70-kD fragment and dimeric
pFN, which has a compact conformation that may reduce
accessibility to III2 binding sites.
Between III1 and III2 is a 17–amino acid “linker” segment
that was present in the MBP-III2 protein. To determine
whether the binding site was located in the type III repeat or
the linker, an MBP protein was generated containing III1–2
but lacking the linker (MBP-III1–2 L) and tested for FN
binding. MBP-III1–2 L bound to FN (Fig. 7 C) and the 70-
kD fragment (unpublished data) to an extent identical to
MBP-III1–2. Similar III1–2 and III1–2 L fragments prepared
from human FN also showed concentration-dependent
binding to 70 kD (unpublished data). Therefore, the site re-
sides in III2 itself and is present in both rat and human FNs.
These results identify repeat III2 as a major FN binding site
and suggest that the lack of fibril formation by FN III1–2 is
due to the absence of this site.
Repositioning of III9–10 cell binding domain
The cell binding domain consisting of an RGD sequence
and synergy site in repeats III9–10 is essential for initiation of
FN matrix assembly by  5 1 integrin (Sechler et al., 1996,
1997). Deletions within repeats III1–7 position the cell bind-
ing domain closer to the NH2-terminal assembly domain
and could affect recFN fibril formation. To eliminate the
possibility that changes in the domain organization can alter
FN assembly, we created FNrIII4–5/9–10. Repeats III4–5 were
replaced with III9–10 and the RGD sequence was deleted
from its native position within the cell binding domain (Fig.
1). Therefore, the only functional III9–10 pair is in the posi-
tion normally occupied by III4–5. CHO 5 cells efficiently
assembled FNrIII4–5/9–10 into a DOC-insoluble fibrillar ma-
trix identical to that of native FN at all time points (Fig. 8,
A–C). Cell cycle progression by CHO 5 cells assembling ei-
ther FN or FNrIII4–5/9–10 was identical, as were the levels of
focal adhesion kinase phosphorylation (unpublished data).
These results demonstrate that the location of the cell bind-
ing domain is not restricted to the center of the molecule
and that displacement toward the NH2 terminus does not
reduce FN function in matrix assembly or its ability to influ-
ence cell cycle progression.
Discussion
FN fibril assembly is initiated by binding to integrin recep-
tors and propagated by FN–FN interactions. The progres-
sion of FN conversion from soluble dimer into insoluble
matrix fibrils is regulated in part by sequences within repeats
III1–7 (Sechler et al., 1996). Using a set of overlapping dele-
tions within this region, we have identified repeat III2 as an
important FN binding site involved in fibril elongation. De-
letions spanning this repeat severely limit fibril assembly and
block formation of DOC-insoluble material. In addition to
implicating III2, our results also eliminate several candidate
sites as important contributors to this process. Specifically,
we have shown that: (a) the III1 repeat and its cryptic FN
binding site are not needed for fibril formation; (b) relatively
large deletions of as many as four repeats do not affect fibril
assembly; and (c) there is considerable pliability in the loca-
tion of the cell binding domain. None of the deletions tested
here had an obvious effect on FN binding to integrins or ini-
tiation of fibril assembly, indicating that reported interac-
tions between III1 and the cell binding domain (Hocking et
al., 1996) are not required in the early stages of FN matrix
assembly.
Our data with FN III1–2 and FN III2–5 show that repeat
III2 participates in the growth phase of FN assembly. Assem-
bly was initiated by both of these recFNs but DOC-insolu-
ble matrix formation was blocked. Together with data show-
ing a direct interaction between III2 and the NH2-terminal
assembly domain of FN, our matrix assembly results indi-
cate that this FN binding site plays a key role in FN–FN in-
teractions during fibril assembly. Repeats III2–3 have been
shown previously to interact with repeats III12–14, an interac-
Figure 8.  Assembly of FNrIII4–5/9–10. CHO 5 cells were cultured 
in the presence of 50  g/ml FNrIII4–5/9–10 for 4 (A) and 16 (B) h. (C) 
DOC-insoluble material was isolated from CHO 5 cells 4 and 16 h 
after incubation with 50  g/ml FNrIII4–5/9–10 and analyzed as in 
Fig. 3. Locations of high molecular mass multimers are indicated 
with arrow and bracket. 180-kD molecular mass standard is indi-
cated by dash. Bar, 10  m. 1086 The Journal of Cell Biology | Volume 154, 2001
tion that appears to contribute to the formation of the com-
pact conformation of soluble FN (Johnson et al., 1999).
Thus, the III2 module may participate in matrix assembly
through interactions with several sites on FN. These interac-
tions may promote elongation by aligning fibrils into a sta-
ble, uniform structure that can then be converted into a
DOC-insoluble form. In the absence of this repeat, fibrils
begin to form but become stalled during elongation and are
inefficiently converted into the DOC-insoluble matrix.
DOC-insolubility of FN fibrils appears to occur through hy-
drophobic protein–protein interactions that resist SDS de-
naturation (Chen and Mosher, 1996). Perhaps III2 partici-
pates in the formation of that hydrophobic interface.
Others have shown the presence of a cryptic FN binding
site in III1 that is exposed by denaturation (Hocking et al.,
1994; Ingham et al., 1997). The apparent affinity of 70 kD
for III2 is higher than that reported for 70 kD binding to
heat-denatured III1 (Hocking et al., 1994). The identifica-
tion of two distinct sites indicates that the III1–2 segment
contains more than one FN binding site, the site in III2 that
is critical for fibril assembly and a cryptic site in III1 that is
dispensable for this process. It is also possible that repeats
III1–2 act as a functional unit to regulate fibril assembly and
promote elongation. For example, interactions between III1
and III2 could regulate the accessibility of an FN binding site.
Previous studies lend support to the idea of cooperation be-
tween these repeats. Both repeats were required for formation
of an in vitro ternary complex with heat-denatured III10 and
the NH2-terminal 70-kD fragment (Hocking et al., 1996).
III2 has also been proposed to contribute to interactions be-
tween III1 and the COOH-terminal heparin binding domain
(Bultmann et al., 1998). Furthermore, the reduced secretion
of recFNs lacking III2 or carrying another type III repeat in
place of III2 indicates that interactions between adjacent re-
peats contribute to domain structure and stability. III1-spe-
cific inhibitory peptides and antibodies have been described
(Chernousov et al., 1987, 1991; Morla and Ruoslahti,
1992). If III1 and III2 do indeed function together, these in-
hibitory reagents may exert their effects indirectly through
disruption of activities mediated by the adjacent III2 module.
Regulated assembly depends in part on conformational
changes in the FN molecule. Accumulating evidence indi-
cates that soluble FN dimers must be converted from a com-
pact inactive form into an “unfolded” activated form in
order for assembly to proceed (Alexander et al., 1979; Will-
iams et al., 1982; Erickson and Carrell, 1983; Rocco et al.,
1983; Ugarova et al., 1995; Schwarzbauer and Sechler,
1999). In vivo, integrin binding induces FN activation and
this may expose the III2 binding site, allowing intermolecu-
lar interactions between cell surface–bound FNs. Whereas
recFNs lacking III2 are able to initiate assembly and form
short fibrils, the significantly reduced levels of DOC-insolu-
ble FN III1–2 suggest that in the absence of the III2 binding
site, this recFN cannot effectively participate in the essential
FN–FN interactions needed for fibrillogenesis. FN mole-
cules can also be induced to associate in solution by the ad-
dition of a peptide corresponding to part of the III1 module
(Morla et al., 1994). This treatment may expose the III2
binding site by local perturbation of intramolecular interac-
tions involving this region of the molecule.
Comparison of the progression of assembly by FN III1–2
with FN III1–7 shows that both initially form short stitches
around cell peripheries and connect to adjacent cells.
FN III1–7 then forms aggregates that prematurely become
insoluble in DOC (Sechler et al., 1996). These aggregates
can apparently be remodeled by binding to adjacent cells
and getting stretched into fibrils. In this way, FN III1–7
forms a relatively normal-appearing fibrillar matrix. On the
other hand, FN III1–2 forms only a few small, DOC-soluble
aggregates that can be converted into predominantly short
fibrils. FN III1–2 does not accumulate in DOC-insoluble
material, nor does it form an extensive fibrillar matrix. The
differences between assembly of FN III1–2 and FN III1–7
suggests that repeats III3–7 contribute to the progression of
FN fibril formation. A few activities have been mapped to
the III3–7 region. Repeats III4–6 can bind to heparin and
DNA under low salt conditions (Hynes, 1990). Cryptic
binding sites within repeat III5 have been reported for acti-
vated  4 1 and  4 7 integrins (Moyano et al., 1997) as
well as for repeat III1 (Hocking et al., 1996). Repeat III1 can
also bind to repeat III7 (Ingham et al., 1997). Thus, it is pos-
sible that during assembly this region of FN interacts with
cell surface or matrix proteins or glycosaminoglycans, and
that these interactions may help to control fibril formation.
FN III1–2 and FN III1–7 probably also differ in the align-
ment of FN dimers into fibrils. For example, binding of the
NH2-terminal assembly domain of one FN III1–7 dimer to
the COOH-terminal heparin domain of another (Bultmann
et al., 1998) would align their cell binding domains rela-
tively close to each other. This juxtaposition could result in
increased clustering of integrins and more stable contacts be-
tween matrix and cytoskeleton, giving the strong connec-
tions needed to remodel aggregates into fibrils and form
DOC-insoluble material. Tension applied to FN fibrils has
been predicted to cause slight unfolding of type III repeats
(Erickson, 1994; Krammer et al., 1999), and this might al-
low the formation of SDS-resistant protein–protein interac-
tions (Chen and Mosher, 1996). On the other hand, the
inclusion of III3–7 may yield a potentially different organiza-
tion of both cell surface receptors and cytoskeletal elements,
thus precluding the formation of a stable matrix.
Clearly, multiple options exist for establishing FN–FN in-
teractions during matrix assembly. For example, the NH2-
terminal assembly domain is required throughout the as-
sembly process, whereas the III2 module participates after
initiation during a phase of fibril growth. This indicates that
different FN binding sites have distinct temporal and spatial
roles, and suggests that control of domain-specific FN inter-
actions may play an important role in regulating the struc-
tural and functional organization of the FN matrix.
Materials and methods
Cell culture
CHO 5, clone 17, and AtT-20 5, clone 11, transfected with a cDNA to
the human  5 integrin subunit have been described previously (Sechler et
al., 1996). For all experiments, CHO 5 cells were cultured in DME supple-
mented with 2 mM glutamine, 1% nonessential amino acids, 100  g/ml
Geneticin (Life Technologies/GIBCO BRL), and 10% fetal calf serum (Hy-
clone Labs) depleted of FN. AtT-20 5 cells were cultured in a 50:50 mix-
ture of Ham’s F12 and DME, plus 20 mM Hepes, pH 7.4, 4 mM glutamine,Fibronectin binding and fibril growth | Sechler et al. 1087
0.25 mg/ml Geneticin (Life Technologies/GIBCO BRL), and 10% fetal calf
serum (Hyclone Labs) and 10% Nu-serum both depleted of FN.
FN cDNA constructions and recombinant protein production
All recFNs were expressed with baculovirus vector pVL1392. Restriction
enzymes and T4 DNA ligase were purchased from New England Biolabs,
Inc. Oligonucleotide primers were prepared by the Synthesis and Sequenc-
ing Facility (Princeton University, Princeton, NJ).
All deletions were created by PCR amplification of rat FN cDNA. A
KpnI site was engineered into each oligonucleotide to join the regions
spanning each deletion. PCR amplification for 25 cycles was performed for
all constructions under the following conditions: 95 C, 30 s; 60 C, 60 s;
and 72 C, 60 s. PCR products were digested with flanking enzymes and in-
serted into the FN cDNA using convenient restriction sites. The following
5  and 3  primers were used to generate the indicated deletions (base posi-
tions of the primers within the FN cDNA are in parentheses and base
changes to introduce the Kpn I sites are underlined):  III1: GGGGTACCT-
GTGCCTGGGTA (1831-1812), CTGGTACCAGCAACACAGTG (2116-
2130);   III4–7: CGGGTACCTCATCGGATCGT (2721-2702), GCGGTAC-
CTCCTCCCACGGA (4065-4084);  III2–5: TGTTGCTGGGTACCGGTGTG
(2124-2105), CCTGGTACCTCTGCGCTCCA (3248-3267). pVL1392
FN III1–2 was prepared by ligating a fragment from FN III1 with a PCR-
amplified fragment made using the primer CTGGTACCGCACCTGAT-
GCGCCTCCAG (2424-2442). pVL1392 FN III4–5 was created by ligating a
5  fragment from pVL1392 FN III4–7 with a 3  fragment from pVL1392
FN III2–5. To generate pVL1392 FNrIII4–5/9–10, a segment spanning repeats
III9–10 was amplified using 5  primer GAGGTACCGGACTCCCCAACTG-
GTTTTG (4552-4570) and 3  primer GAGGTACCGCTGTTTGATAAT-
TGATGGAAACTGGC (5098-5073) containing KpnI sites (underlined). The
resulting KpnI fragment was then inserted at the engineered KpnI site in
pVL1392 FN III4–5 and a segment encoding an RGD deletion was inserted
into the cell binding domain (Schwarzbauer, 1991). All regions obtained
from PCR products were verified by DNA sequence analysis.
Recombinant baculoviruses were created and recombinant proteins and
rat pFN were purified as described (Sechler et al., 1996, 1997). Yields of
recFNs were at least 0.8 mg/100 ml of culture supernatant. The identity of
FN III1 and FN III1–2 recombinant baculoviruses was further confirmed us-
ing DNA isolated from infected High Five insect cells as template for PCR
amplification with flanking primers. Correctly sized PCR products were ob-
tained as analyzed by PAGE before and after restriction with KpnI.
Immunofluorescence
As described in Sechler et al. (1996), CHO 5 and AtT-20 5 cells were
seeded in medium containing FN-depleted serum and plated onto glass
coverslips in a 24-well dish or four-well chamber slides at a concentration
of 1.5   10
5 and 4   10
5, respectively. After an overnight incubation, fresh
medium was added along with either pFN or purified recFN and incubated
for the times indicated. Cell layers were fixed with 3.7% formaldehyde and
stained with a 1:1,000 dilution of IC3 ascites in PBS with 2% ovalbumin
followed by a 1:400 dilution of fluorescein-conjugated goat anti–mouse
secondary antibody. Stained cells were mounted with FluoroGuard (Bio-
Rad Laboratories), and fibrils were visualized with a Nikon Optiphot-2 mi-
croscope. Images were collected with a DEI-750 cooled CCD camera (Op-
tronics Engineering) and transferred to a Macintosh G3 computer with an
LG3 frame grabber (Scion Corp.) and Adobe Photoshop v. 5.0.
Isolation and detection of DOC-soluble and -insoluble matrix
DOC-soluble and -insoluble material was isolated from CHO 5 cells cul-
tured in a 24-well dish with pFN or recFNs as described above. After the
indicated time periods, cells were washed with serum-free DME and lysed
with 200  l of DOC lysis buffer (2% deoxycholate, 0.02 M Tris-HCl, pH
8.8, 2 mM phenylmethylsulfonyl fluoride, 2 mM EDTA, 2 mM iodoacetic
acid, and 2 mM N-ethylmaleimide) per well. Lysates were separated into
DOC-soluble and -insoluble fractions that were analyzed by SDS-PAGE.
Immunodetection was performed as described (Sechler et al., 1996) using
ascites fluid from rat FN–specific monoclonal antibody IC3 at a dilution of
1:1,000. Immunoblots were developed with Super Signal chemilumines-
cence reagents (Pierce Chemical Co.). Band intensities were quantified at
two exposure times using IPLab software (Mac v. 3.5; Scanalytics, Inc.).
Expression of bacterial fusion proteins and FN binding assays
Rat FN cDNA fragments encoding repeat III1 or III2 were inserted into
pMAL-cRI (New England Biolabs, Inc.) for expression as MBP fusion pro-
teins. III1 spanned amino acid positions 604–700 (TYP … TTS) and III2 ex-
tended from residue 701 to 808 (AST … QTT). BamHI sites and XbaI sites
were engineered at the 5  and 3  ends, respectively. PCR amplification us-
ing primers homologous to sequences flanking the 17–amino acid linker
(701–717) was used to replace these residues (AST … APF) with a KpnI site
to generate III1–2 L. Escherichia coli TB1 cells expressing individual MBP fu-
sion proteins were lysed with B-PER (Pierce Chemical Co.) and proteins
were purified by amylose resin affinity chromatography following the man-
ufacturer’s recommendations. Rat pFN, recombinant 70-kD fragment, MBP,
and MBP-III1–2 were purified as described previously (Aguirre et al., 1994).
Solid phase binding assays were performed essentially as described by
Aguirre et al. (1994). Fusion proteins containing III1, III2, III1–2, and III1–2 L
were immobilized on Nunc Maxisorp microtiter plates by overnight incu-
bation at the indicated concentrations. Relative amounts of immobilized
proteins were determined by ELISA with an anti-MBP antiserum. After
washing and blocking with 1% BSA in PBS, wells were incubated with rat
pFN at 50  g/ml or NH2-terminal 70-kD fragment of FN at 30  g/ml for
2 h at room temperature. Bound FN and 70 kD were detected and quanti-
fied by ELISA using anti–rat FN monoclonal antibody 5G4 or anti–70-kD
polyclonal antiserum R457.
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